 Pharmacokinetics acyclovir term human pregnancy neonate Concern neonatal herpes delivery infants women history genital herpes antiviral drug acyclovir genital herpes simplex virus recurrences nonpregnant adults administration pregnant women recurrent genital herpes herpes simplex virus recurrences cesarean section rate population pharmacokinetics safety patient tolerance suppressive oral acyclovir mg mg hours pregnant women history recurrent herpes simplex virus weeks gestation delivery mean SD plasma levels mg groups peak mumol/L steady-state trough mumol/L steady-state peak mumol/L late gestation maternal acyclovir pharmacokinetics similar nonpregnant adults studies Acyclovir amniotic fluid accumulation fetus mean maternal/infant plasma ratio delivery Acyclovir toxicity mothers infants administration acyclovir mg hours appropriate use efficacy safety study suppression herpes simplex virus recurrences last weeks pregnancy